Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Diagnostic Pathology|June 17, 2019
Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histologyC Elfgen, B Papassotiropoulos, Z Varga, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Fenretinide (4-HPR) in chemoprevention of oral leukoplakiaF Chiesa, N Tradati, M Marazza, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 1, 1989
[Precancerous oral lesions. Diagnostic and therapeutic protocol]F Berrino, F Chiesa, A Carrassi, et al.
Allergy|February 24, 2015
Asthma phenotypes and lung function up to 16 years of age-the BAMSE cohortJ Hallberg, P Thunqvist, E S Schultz, et al.
European Journal of Cancer. Part B, Oral Oncology|March 1, 1995
European School of Oncology Advisory report to the European Commission for the Europe Against Cancer Programme: oral carcinogenesis in EuropeP Boyle, G J Macfarlane, W J Blot, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|October 25, 2012
Metastasis to the right stellate ganglion and vagal nerve: pathological alterations causing sudden death. A case reportF Maffini, G Pruneri, N Colombo, et al.
Anticancer Research|January 19, 1999
Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practiceF Chiesa, N Tradati, S Mauri, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakiaG De Palo, U Veronesi, E Marubini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 11, 2006
Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node conceptC De Cicco, G Trifirò, L Calabrese, et al.
Oncology|August 21, 2008
Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II studyD Ferrari, F Chiesa, C Codecà, et al.
Pageof 9